Future perspectives for treating patients with geographic atrophy.

Authors:
Loewenstein A; Trivizki O.

Journal:
Graefes Arch Clin Exp Ophthalmol

Publication Year: 2022

DOI:
10.1007/s00417-022-05931-z

PMCID:
PMC10198833

PMID:
36520185

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Graefes Arch Clin Exp Ophthalmol

Abbreviation: Graefes Arch Clin Exp Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A case study in applying artificial intelligence-based named entity recognition to develop an autom…
Macri CZ; Teoh SC; Bacchi S and 5 more (2023) - Transparency Score: 3/6
Accelerated corneal cross-linking (18mW/cm2 for 5 min) with HPMC-riboflavin in progressive keratoco…
Friedrich J; Sandner A; Nasseri A and 2 more (2023) - Transparency Score: 3/6
A mini-invasive surgical technique for Carlevale IOL implantation: case series study and descriptio…
Danese C; Di Bin F; Lanzetta P. (2023) - Transparency Score: 3/6
A novel quick contrast sensitivity function test in Chinese adults with myopia and its related para…
Ye Y; Aruma A; Zhao W and 3 more (2023) - Transparency Score: 3/6
A rabbit model for outer retinal atrophy caused by surgical RPE removal.
Al-Nawaiseh S; Krötz C; Rickmann A and 6 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approvalThis review article does not contain any studies with human participants or animals performed by any of the others. Conflict of interestAnat Loewenstein is a consultant to Iveric Bio, Beyeonics, Bayer, WebMD, Allergan, Roche, Novartis, Notal Vision. Omer Trivizki declares no conflicts of interest. Conflict of interest Anat Loewenstein is a consultant to Iveric Bio, Beyeonics, Bayer, WebMD, Allergan, Roche, Novartis, Notal Vision. Omer Trivizki declares no conflicts of interest."

Evidence found in paper:

"Funding The medical writing support was provided by IMPRINT Science, New York, NY, USA and funded by Iveric Bio."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025